Skip to main content
SpringerLink
Log in
Book cover

Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds pp 377–385Cite as

The Role of the GP-TCM Research Association to Modernization and Globalization of Traditional Chinese Medicine

  • Chapter
  • First Online:

  • 1679 Accesses

Abstract

Traditional Chinese Medicine (TCM) is an ancient medical system using experience-based therapies such as acupuncture and herbal medicine, which has been practised for thousands of years in the diagnosis, prevention and treatment of diseases in Asia.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Tang JL, Liu BY, Ma KW (2008) Traditional Chinese medicine. Lancet 372:1938–1940

    Article  PubMed  Google Scholar 

  2. Unschuld PU (1999) The past 1000 years of Chinese medicine. Lancet 354(4):SIV9

    Google Scholar 

  3. Scheid V (1999) The globalization of Chinese medicine. Lancet 354(4):SIV10

    Google Scholar 

  4. Cai J (1988) Integration of traditional Chinese medicine with western medicine—right or wrong? Soc Sci Med 27:521–529

    Article  PubMed  CAS  Google Scholar 

  5. Qiu J (2007) China plans to modernize traditional medicine. Nature 446:590–591

    Article  PubMed  CAS  Google Scholar 

  6. Uzuner H, Fan TP, Dias A, Guo DA, El-Nezami HS, Xu Q (2010) Establishing an EU-China consortium on traditional Chinese medicine research. Chin Med 5:42

    Article  PubMed  Google Scholar 

  7. Uzuner H, Bauer R, Fan TP, Guo DA, Dias A, El-Nezami H, Efferth T, Williamson EM, Heinrich M, Robinson N, Hylands PJ, Hendry BM, Cheng YC, Xu Q (2012) Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities. J Ethnopharmacol 140:458–468

    Article  PubMed  Google Scholar 

  8. Sheng-Ji P (2001) Ethnobotanical approaches of traditional medicine studies: some experiences from Asia. Pharm Biol 39(1):74–79

    Article  PubMed  Google Scholar 

  9. Qian ZZ, Dan Y, Liu YZ, Peng Y (2010) Pharmacopoeia of the People’s Republic of China (2010 edition): a milestone in development of China’s healthcare. Chin Herb Med 2(2):157–160

    Google Scholar 

  10. Bauer R, Franz G (2010) Modern European monographs for quality control of Chinese herbs. Planta Med 76(17):2004–2011

    Article  PubMed  CAS  Google Scholar 

  11. Zhang B, Peng Y, Zhang Z, Liu H, Qi Y, Liu S, Xiao P (2010) GAP production of TCM herbs in China. Planta Med 76(17):1948–1955

    Article  PubMed  CAS  Google Scholar 

  12. Heuberger H, Bauer R, Friedl F, Heubl G, Hummelsberger J, Nögel R, Seidenberger R, Torres-Londoño P (2010) Cultivation and breeding of Chinese medicinal plants in Germany. Planta Med 76(17):1956–1962

    Article  PubMed  CAS  Google Scholar 

  13. Zhao Z, Guo P, Brand E (2012) The formation of daodi medicinal materials. J Ethnopharmacol 140:476–481

    Article  PubMed  Google Scholar 

  14. Pferschy-Wenzig E-M, Bauer R (2009) Quality control of Chinese herbal drugs. In: Houghton P, Mukherjee PK (eds) Evaluation of herbal medicinal products: perspectives on quality, safety, and efficacy. Pharmaceutical Press, London, pp 1–502

    Google Scholar 

  15. Heubl G (2010) New aspects of DNA-based authentication of Chinese medicinal plants by molecular biological techniques. Planta Med 76(17):1963–1974

    Article  PubMed  CAS  Google Scholar 

  16. Liang YZ, Xie PS, Chan K (2010) Perspective of chemical fingerprinting of Chinese herbs. Planta Med 76(17):1997–2003

    Article  PubMed  CAS  Google Scholar 

  17. Sheridan H, Krenn L, Jiang R, Sutherland I, Ignatova S, Marmann A, Liang X, Sendker J (2012) The potential of metabolic fingerprinting as a tool for the modernisation of TCM preparations. J Ethnopharmacol 140:482–491

    Article  PubMed  CAS  Google Scholar 

  18. Tilton R, Paiva AA, Guan JQ, Marathe R, Jiang Z, van Eyndhoven W, Bjoraker J, Prusoff Z, Wang H, Liu SH, Cheng YC (2010) A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906. Chin Med 5:30

    Article  PubMed  Google Scholar 

  19. Zhao ZZ, Liang ZT, Chan K, Lu GH, Lee ELM, Chen HB, Li L (2010) A unique issue in the standardization of Chinese materia medica: processing. Planta Med 76:1975–1986

    Article  PubMed  CAS  Google Scholar 

  20. Chan K, Shaw D, Simmonds MS, Leon CJ, Xu Q, Lu A, Sutherland I, Ignatova S, Zhu YP, Verpoorte R, Williamson EM, Duez P (2012) Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. J Ethnopharmacol 140:469–475

    Article  PubMed  Google Scholar 

  21. Wang J (2010) Evidence-based medicine in China. Lancet 375:532–533

    Article  PubMed  Google Scholar 

  22. Jiang M, Yang J, Zhang C, Liu B, Chan K, Cao H, Lu A (2010) Clinical studies with traditional Chinese medicine in the past decade and future research and development. Planta Med 76(17):2048–2064

    Article  PubMed  CAS  Google Scholar 

  23. Normile D (2003) Asian medicine. The new face of traditional Chinese medicine. Science 299:188–190

    Article  PubMed  CAS  Google Scholar 

  24. Flower A, Witt C, Liu JP, Ulrich-Merzenich G, Yu H, Lewith G (2012) Guidelines for randomised controlled trials investigating Chinese herbal medicine. J Ethnopharmacol 140:550–554

    Article  PubMed  Google Scholar 

  25. Jiang M, Lu C, Zhang C, Yang J, Tan Y, Lu A, Chan K (2012) Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol 140:634–642

    Article  PubMed  Google Scholar 

  26. van der Greef J (2011) Perspective: all systems go. Nature 480:S87

    Article  PubMed  Google Scholar 

  27. van der Greef J, Hankemeier T, McBurney RN (2006) Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? Pharmacogenomics 7:1087–1094

    Article  PubMed  Google Scholar 

  28. Melchart D, Weidenhammer W, Streng A, Reitmayr S, Hoppe A, Ernst E, Linde K (2004) Prospective investigation of adverse effects of acupuncture in 97733 patients. Arch Intern Med 164:104–105

    Article  PubMed  Google Scholar 

  29. Witt CM, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B, Willich SN, Melchart D (2007) The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128:264–271

    Article  PubMed  Google Scholar 

  30. Berman BM, Lao L, Langenberg P, Lee WL, Gilpin AM, Hochberg MC (2004) Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 141:901–910

    PubMed  Google Scholar 

  31. Haake M, Müller HH, Schade-Brittinger C, Basler HD, Schäfer H, Maier C, Endres HG, Trampisch HJ, Molsberger A (2007) German acupuncture trials (GERAC) for chronic low back pain: randomized, multicenter, blinded, parallel-group trial with 3 groups. Arch Intern Med 167:1892–1898

    Article  PubMed  Google Scholar 

  32. Linde K, Streng A, Jürgens S, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, Pfaffenrath V, Hammes MG, Weidenhammer W, Willich SN, Melchart D (2005) Acupuncture for patients with migraine: a randomized controlled trial. JAMA 293:2118–2125

    Article  PubMed  CAS  Google Scholar 

  33. Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N, Fisher P, Van Haselen R (2004) Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. BMJ 328:744

    Article  PubMed  Google Scholar 

  34. Jia J, Yu Y, Deng JH, Robinson N, Bovey M, Cui YH, Liu HR, Ding W, Wu HG, Wang XM (2012) A review of omics research in acupuncture: the relevance and future prospects for understanding the nature of meridians and acupoints. J Ethnopharmacol 140:594–603

    Article  PubMed  CAS  Google Scholar 

  35. Robinson N, Lorenc A, Ding W, Jia J, Bovey M, Wang XM (2012) Exploring practice characteristics and research priorities of practitioners of traditional acupuncture in China and the EU-A survey. J Ethnopharmacol 140:604–613

    Article  PubMed  Google Scholar 

  36. van der Greef J, van Wietmarschen H, Schroën J, Wang M, Hankemeier T, Xu G (2010) Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine. Planta Med 76(17):2036–2047

    Article  PubMed  Google Scholar 

  37. Buriani A, Garcia-Bermejo ML, Bosisio E, Xu Q, Li H, Dong X, Simmonds MS, Carrara M, Tejedor N, Lucio-Cazaña J, Hylands PJ (2012) Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future. J Ethnopharmacol 140:535–544

    Article  PubMed  Google Scholar 

  38. Zhang A, Sun H, Wang Z, Sun W, Wang P, Wang X (2010) Metabolomics: towards understanding traditional Chinese medicine. Planta Med 76(17):2026–2035

    Article  PubMed  CAS  Google Scholar 

  39. Tejedor Garcia N, Garcia Bermejo L, Fernandez Martinez AB, Olmos Centenera G, Kumari R, Xu Q, Cheng X, Watson S, Lucio Cazaña FJ (2012) MEDLINE-based assessment of animal studies on Chinese herbal medicine. J Ethnopharmacol 140:545–549

    Article  PubMed  Google Scholar 

  40. Barlow DJ, Buriani A, Ehrman T, Bosisio E, Eberini I, Hylands PJ (2012) In-silico studies in Chinese herbal medicines’ research: Evaluation of in silico methodologies and phytochemical data sources, and a review of research to date. J Ethnopharmacol 140:526–534

    Article  PubMed  CAS  Google Scholar 

  41. Chen ST, Dou J, Temple R, Agarwal R, Wu KM, Walker S (2008) New therapies from old medicines. Nat Biotechnol 26:1077–1083

    Article  PubMed  CAS  Google Scholar 

  42. Biochemistry Stone R (2008) Lifting the veil on traditional Chinese medicine. Science 319:709–710

    Article  Google Scholar 

  43. Zhang X, Liu Y, Guo Z, Feng J, Dong J, Fu Q, Wang C, Xue X, Xiao Y, Liang X (2012) The herbalome—an attempt to globalize Chinese herbal medicine. Anal Bioanal Chem 402:573–581

    Article  PubMed  CAS  Google Scholar 

  44. Shaw D (2010) Toxicological risks of Chinese herbs. Planta Med 17:2012–2018

    Article  Google Scholar 

  45. Debelle FD et al (2008) Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74:158–169

    Article  PubMed  CAS  Google Scholar 

  46. Fu PP, Xia QS, Lin G, Chou MW (2004) Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 36:1–55

    Article  PubMed  CAS  Google Scholar 

  47. Tai YT, But PP, Young K, Lau CP (1993) Adverse effects from traditional Chinese medicine. Lancet 341:892

    Article  PubMed  CAS  Google Scholar 

  48. Fugh-Berman A (2000) Herb-drug interactions. Lancet 355:134–138

    Article  PubMed  CAS  Google Scholar 

  49. Ouedraogo M, Baudoux T, Stévigny C, Nortier J, Colet JM, Efferth T, Qu F, Zhou J, Chan K, Shaw D, Pelkonen O, Duez P (2012) Review of current and “omics” methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines. J Ethnopharmacol 140:492–512

    Article  PubMed  CAS  Google Scholar 

  50. Shaw D, Graeme L, Pierre D, Elizabeth W, Kelvin C (2012) Pharmacovigilance of herbal medicine. J Ethnopharmacol 140:513–518

    Article  PubMed  Google Scholar 

  51. Zhang L, Yan J, Liu X, Ye Z, Yang X, Meyboom R, Chan K, Shaw D, Duez P (2012) Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. J Ethnopharmacol 140:519–525

    Article  PubMed  Google Scholar 

  52. Youns M, Hoheisel JD, Efferth T (2010) Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine. Planta Med 76(17):2019–2025

    Article  PubMed  CAS  Google Scholar 

  53. Fan TP, Deal G, Koo HL, Rees D, Sun H, Chen S, Dou JH, Makarov VG, Pozharitskaya ON, Shikov AN, Kim YS, Huang YT, Chang YS, Jia W, Dias A, Wong VC, Chan K (2012) Future development of global regulations of Chinese herbal products. J Ethnopharmacol 140:568–586

    Article  PubMed  Google Scholar 

  54. Dobos GJ, Tan L, Cohen MH, McIntyre M, Bauer R, Li X, Bensoussan A (2005) Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country. Complement Ther Med 13(3):183–190

    Article  PubMed  CAS  Google Scholar 

  55. Pelkonen O, Pasanen M, Lindon JC, Chan K, Zhao L, Deal G, Xu Q, Fan TP (2012) Omics and its potential impact on R&D and regulation of complex herbal products. J Ethnopharmacol 140:587–593

    Article  PubMed  CAS  Google Scholar 

  56. Vlietinck A, Pieters L, Apers S (2009) Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union. Planta Med 75(7):683–688

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. TCM Research Center Graz, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria

    Rudolf Bauer

  2. Shanghai Research Center for TCM Modernization, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

    De-an Guo

  3. Institute of Pharmaceutical Science, King’s College London, London, UK

    Peter Hylands

  4. Department of Pharmacology, University of Cambridge, Cambridge, UK

    Tai-Ping Fan

  5. Department of Renal Medicine, King’s College London, London, UK

    Qihe Xu

Authors
  1. Rudolf Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. De-an Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Hylands
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tai-Ping Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qihe Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rudolf Bauer .

Editor information

Editors and Affiliations

  1. , Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Bayview Boulevard Street 251, Baltimore, 21224-6825, Maryland, USA

    Evandro Fei Fang

  2. , School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, Hong Kong SAR

    Tzi Bun Ng

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Bauer, R., Guo, Da., Hylands, P., Fan, TP., Xu, Q. (2013). The Role of the GP-TCM Research Association to Modernization and Globalization of Traditional Chinese Medicine. In: Fang, E., Ng, T. (eds) Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6214-5_25

Download citation

Publish with us

Policies and ethics

Search

Navigation